| 2024-10-17 |
股东大会：
将于2024-11-22召开股东大会
会议内容 ▼▲
- 1.To elect five directors nominated by Novo’s Board of Directors, based on the recommendation of Novo’s independent directors, to serve for a one-year term following approval by the stockholders at the Annual Meeting;
2.To approve the potential issuance of shares of Novo’s common stock in excess of 19.99% of our outstanding common stock pursuant to listing rules of the Nasdaq Capital Market;
3.To approve the amendment of Novo’s articles of incorporation, as amended, to effectuate a reverse stock split of Novo’s outstanding shares of common stock, par value $0.001 per share, at a ratio of no less than 1-for-10 and no more than 1-for-30, with such ratio to be determined at the sole discretion of Novo’s Board of Directors;
4.To ratify the appointment of Fruci & Associates II, PLLC as Novo’s independent registered public accounting firm for the fiscal year ending August 31, 2025;
5.To transact such other business as may properly come before the Annual Meeting and/or any adjournment or postponement thereof.
|
| 2024-07-19 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-1.2美元,归母净利润-2116.84万美元,同比去年增长-110.54%
|
| 2024-05-31 |
复牌提示：
2024-05-31 09:42:31 停牌，复牌日期 2024-05-31 09:47:31
|
| 2024-04-15 |
详情>>
股本变动：
变动后总股本1905.45万股
|
| 2024-04-15 |
详情>>
业绩披露：
2024年中报每股收益-0.43美元,归母净利润-742.65万美元,同比去年增长13.21%
|
| 2024-01-22 |
详情>>
业绩披露：
2024年一季报每股收益-0.28美元,归母净利润-468.03万美元,同比去年增长-18.93%
|
| 2023-12-14 |
详情>>
业绩披露：
2023年年报每股收益-1.3美元,归母净利润-1321.46万美元,同比去年增长59.77%
|
| 2023-11-07 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2023-08-18 |
股东大会：
将于2023-09-29召开股东大会
会议内容 ▼▲
- 1.To elect five directors nominated by Novo’s Board of Directors, based on the recommendation of Novo’s independent directors, to serve for a one-year term following approval by the stockholders at the Annual Meeting;
2.To approve the 2023 Equity Incentive Plan;
3.To approve the amendment of Novo’s Amended and Restated Articles of Incorporation, as amended (the “Articles of Incorporation”), to effectuate a reverse stock split of Novo’s outstanding shares of common stock, at a ratio of no less than 1-for-5 and no more than 1-for-15, with such ratio to be determined at the sole discretion of the Board (the “Reverse Stock Split”);
4.To ratify the appointment of Fruci & Associates II, PLLC as Novo’s independent registered public accounting firm for the fiscal year ending August 31, 2023;
5.To transact such other business as may properly come before the Annual Meeting and/or any adjournment or postponement thereof.
|
| 2023-07-17 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.12美元,归母净利润-1005.41万美元,同比去年增长3.53%
|
| 2023-05-26 |
详情>>
业绩披露：
2023年中报每股收益-0.15美元,归母净利润-855.68万美元,同比去年增长-29.42%
|
| 2023-05-24 |
详情>>
业绩披露：
2023年一季报每股收益-0.12美元,归母净利润-393.54万美元,同比去年增长-117.84%
|
| 2023-04-03 |
详情>>
业绩披露：
2022年年报每股收益-1.13美元,归母净利润-3284.92万美元,同比去年增长-636.18%
|
| 2022-07-14 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-0.37美元,归母净利润-1042.18万美元,同比去年增长-313.15%
|
| 2022-07-08 |
股东大会：
将于2022-08-19召开股东大会
会议内容 ▼▲
- 1.To elect five directors nominated by Novo’s Board of Directors, based on the recommendation of Novo’s independent directors, to serve for a one-year term following approval by the stockholders at the Annual Meeting;
2.To hold a non-binding advisory vote on executive compensation;
3.To hold a non-binding advisory vote on the frequency of executive compensation advisory votes;
4.To ratify the appointment of SRCO Professional Corporation as Novo’s independent registered public accounting firm for the fiscal year ending August 31, 2022;
5.To transact such other business as may properly come before the Annual Meeting and/or any adjournment or postponement thereof.
|
| 2022-04-19 |
详情>>
内部人交易：
Oliva Robert Letterio共交易3笔
|
| 2022-04-13 |
详情>>
业绩披露：
2022年中报每股收益-0.24美元,归母净利润-661.18万美元,同比去年增长-213.15%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|